首页> 外国专利> Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof

Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof

机译:双氯芬酸药学上可接受的盐的缓释药物基质片剂及其制备方法

摘要

The present invention provides a novel sustained release composition and method for making such a composition of diclofenac and its pharmaceutically acceptable salts. The composition of the present invention provides a sustained release formulation of diclofenac and pharmaceutically acceptable salts thereof which is suitable for once daily administration and provides controlled and long lasting in vivo release. The composition comprises: (a) about 5-25% by weight of hydroxyethyl cellulose; (b) about 5-75% by weight of lactose; (c) about 0-3% by weight of silicone dioxide; (d) about 0.5-5% by weight of PVP; (e) about 3% by weight of talc; and f) about 3% by weight of magnesium stearate.
机译:本发明提供了新颖的持续释放组合物和制备双氯芬酸及其药学上可接受的盐的组合物的方法。本发明的组合物提供了一种双氯芬酸及其药学上可接受的盐的缓释制剂,其适合于每日一次给药并且提供了受控且持久的体内释放。该组合物包含:(a)约5-25重量%的羟乙基纤维素; (b)约5-75%(重量)的乳糖; (c)约0-3%(重量)的二氧化硅; (d)约0.5-5重量%的PVP; (e)滑石粉的重量约<3%; f)硬脂酸镁重量的<3%。

著录项

  • 公开/公告号US6312724B1

    专利类型

  • 公开/公告日2001-11-06

    原文格式PDF

  • 申请/专利权人 ODIDI ISA;ODIDI AMINA;

    申请/专利号US19980054942

  • 发明设计人 ISA ODIDI;

    申请日1998-04-03

  • 分类号A61K92/20;A61K91/00;

  • 国家 US

  • 入库时间 2022-08-22 01:02:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号